Skip to main content
OpenTrials
Completed

NCT Number: NCT03819725

Monitoring of Postprandial Glycemic Variability in Healthy Young Infants

To measure and quantify the postprandial glucose variations in response to a meal in the healthy 6-12 months old child and correlate this response with the composition of this meal.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–12 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pediatric Endocrinology, Diabetology and Obesity Unit, Service of Pediatrics, Lausanne University Hospital

Lausanne, Canton of Vaud, 1011, Switzerland

About this study

14 full-term infants (boys and girls) aged six to twelve months and fed a diversified diet including infant formula, solid foods such as mixed meat and vegetable preparation or marketed preparations will be recruited. Children will be recruited in the Lausanne Childrens hospital and only be included in the study whenin good general health.

FreeStyle® Libre Pro Interstitial Glucose Meter will be applied on the last day before discharge from the hospital after skin preparation with anesthetic cream (Emla®) during hospitalization and measurements will be recorded during 2-5 days.

It is not intended to measure capillary or venous blood glucose levels during this study. However, if blood is collected during hospitalization, blood glucose will be measured in parallel with the interstitial glucose measured with the device.

The child will follow his usual diet without modifications. The amount of food consumed by the child as well as the length of the meals will be recorded by the parents. For meals made by the parents they will be asked to keep a sample not seen to analyze their carbohydrate content. The total carbohydrate content will be measured .

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Term infants (boys and girls)
  • 6 to 12 months old
  • In good general health
  • Nourished with diverse nutrition including infant formula, solid foods such as mixed meat and vegetable preparation or marketed preparations
  • Infant child: if the child is breastfed partially, it can be included in the study. In this case, only samples of a food supplement will be collected for evaluation of the composition.
  • Hospitalized at the Lausanne Children's Hospital for non-severe reasons that do not affect or suspect to affect glucose metabolism
  • Measures of feeding (time and compositions with samples) feasible for 3 consecutive days by the parents at home

Exclusion criteria

  • Child born premature
  • One or both parents with type 2 diabetes or gestational diabetes
  • Child totally breastfed
  • Chronic skin condition such as eczema, excessive dryness.
  • Allergy known to adhesive plaster
  • Infectious diseases affecting the skin (eg chickenpox, scarlet fever,)
  • disorders of cutaneous microcirculation
  • Infants suffering from diseases affecting nutrition or digestion (diarrheal gastroenteritis) and children undergoing antibiotic treatment that may affect gastrointestinal absorption
  • Magnetic Resonance Imaging (MRI), Computed Tomography (CT), or Diathermy Therapy

Treatment and study plan

Glucose monitoring

Device

FreeStyle® Libre Pro Interstitial Glucose Meter will be applied after skin preparation with anesthetic cream (Emla®) . Interstitial glucose measurements will be recorded during 2-5 days and during meals.

Primary outcomes

  1. Prandial glucose variations

    Time frame: up to 5 days

    Change of preprandial to postprandial glucose measurements, expressed in mmol/l

Sponsors and collaborators

Lead sponsor

University of Lausanne Hospitals

Other

Collaborators

  • Société des Produits Nestlé (SPN)

Registry information

Acronym: IGVM

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Jan 28, 2019
Registry last updated
Jun 22, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.